The evaluation of safety and efficacy of Pembrolizumab (CinnaGen Co, Iran) in patients with COVID-19
Latest Information Update: 03 Aug 2020
At a glance
- Drugs Pembrolizumab (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Sponsors CinnaGen
- 03 Aug 2020 New trial record